Vertex Mar 10, 2026 Vertex to seek approval of IgAN drug after Phase III success - Clinical Trials Arena
Vertex Mar 10, 2026 Vertex races to FDA after phase 3 kidney disease data impress analysts - Fierce Biotech
Vertex Jan 20, 2026 Vertex to Announce Fourth Quarter and Full Year 2025 Financial Results on February 12th - Vertex Pharmaceuticals Newsroom
BioPharma Dive Jan 12, 2026 AbbVie buys into PD-1/VEGF sweepstakes; Alnylam and Vertex set expectations